CTMX
CytomX Therapeutics Inc
2.60$
+4.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 519.0% | 319.1% | 170.5% | 385.7% | 99.4% | 103.1% | 207.3% | 160.0% | 281.2% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | 7.5% | – | 11.3% | 13.3% | 7.4% | 6.4% | 6.2% | 5.4% | 1.8% | 1.1% | 1.8% | – | 1.1% | – | 1.9% | – | 76.9% | 2.4% | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 92.5% | 100.0% | 100.0% | 86.7% | 100.0% | 93.6% | 93.8% | 94.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.6% | 100.0% | 98.6% | |
| 386.1% | 244.7% | 125.1% | 320.8% | 119.8% | 76.5% | 158.3% | 119.8% | 220.2% | 246.8% | 123.4% | 342.1% | 261.1% | 440.2% | 86.3% | 144.9% | 135.2% | 134.4% | 140.1% | 160.2% | 165.7% | 182.2% | 338.0% | 242.4% | 267.2% | 97.2% | 87.7% | 81.3% | 39.5% | 72.9% | 53.2% | 100.2% | 63.9% | 38.8% | 37.1% | 71.4% | 256.6% | 3,202.9% | 187.5% | 1,241.0% | 400.9% | |
| 145.7% | 82.2% | 48.8% | 69.1% | 25.9% | 28.1% | 51.9% | 42.4% | 65.0% | 78.2% | 32.8% | 104.4% | 79.0% | 111.3% | 19.3% | 52.3% | 48.5% | 55.9% | 57.8% | 57.7% | 63.0% | 47.9% | 116.6% | 91.4% | 94.1% | 38.1% | 33.9% | 29.9% | 25.8% | 29.4% | 18.7% | 33.4% | 23.8% | 14.8% | 18.5% | 35.5% | 107.8% | 1,110.1% | 104.2% | 536.0% | 175.3% | |
| 531.8% | 326.9% | 173.9% | 389.9% | 145.7% | 104.6% | 210.2% | 162.1% | 285.3% | 325.0% | 156.2% | 446.5% | 340.1% | 551.5% | 105.6% | 197.2% | 183.7% | 190.3% | 197.8% | 217.9% | 228.7% | 225.8% | 454.7% | 333.8% | 353.2% | 147.2% | 117.7% | 107.3% | 52.6% | 102.3% | 71.9% | 133.7% | 87.7% | 53.6% | 55.6% | 106.9% | 364.4% | 4,313.0% | 289.3% | 1,777.1% | 574.8% | |
| -431.8% | -226.9% | -73.9% | -289.9% | -45.7% | -4.6% | -110.2% | -62.1% | -185.3% | -225.0% | -56.2% | -346.5% | -240.1% | -451.5% | -5.6% | -97.2% | -83.7% | -90.3% | -97.8% | -117.9% | -128.7% | -133.4% | -354.7% | -233.8% | -266.5% | -47.2% | -24.1% | -13.5% | 42.0% | -2.3% | 28.1% | -33.7% | 12.3% | 46.4% | 44.4% | -6.9% | -264.4% | -4,213.0% | -191.8% | -1,677.1% | -476.2% | |
| 14.0% | 6.2% | 1.8% | 4.1% | 3.3% | 0.8% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | 0.8% | 2.0% | 5.5% | 6.8% | 10.0% | – | – | 8.8% | – | – | – | – | – | – | – | – | – | – | – | |
| -424.5% | -224.2% | -70.9% | -287.8% | -42.5% | 0.4% | -101.5% | -54.6% | -167.3% | -203.3% | -47.9% | -321.3% | -221.2% | -433.3% | -3.4% | -94.4% | -82.7% | -89.8% | -97.4% | -118.1% | -128.4% | -133.0% | -353.8% | -229.5% | -260.7% | -43.6% | -14.1% | -4.4% | 22.0% | 7.2% | 33.4% | -25.8% | 17.3% | 49.7% | 46.3% | -0.5% | -237.6% | -3,990.3% | -177.3% | -1,453.2% | -434.0% | |
| 0.0% | -0.4% | 0.0% | 0.3% | -0.1% | -1.9% | 7.7% | 8.4% | 20.0% | 77.7% | 0.0% | -26.2% | -18.6% | -5.1% | -28.1% | -2.7% | -1.1% | -0.6% | -0.4% | -0.3% | -0.4% | -0.4% | -0.9% | -4.3% | -5.8% | -6.8% | -10.0% | -9.3% | 10.7% | 4.0% | 0.1% | 0.2% | 0.2% | 0.2% | 0.1% | 0.3% | 1.0% | 8.1% | 0.6% | 4.2% | 1.3% | |
| -424.5% | -223.7% | -70.9% | -288.1% | -42.4% | 2.3% | -109.2% | -63.0% | -187.3% | -281.0% | -47.9% | -321.3% | -221.2% | -428.3% | 24.6% | -94.4% | -82.7% | -89.8% | -97.4% | -118.1% | -128.4% | -133.0% | -353.8% | -229.5% | -260.7% | -43.6% | -14.1% | -4.4% | 11.3% | 3.1% | 33.3% | -26.0% | 17.2% | 49.6% | 46.2% | -0.8% | -238.6% | -3,998.5% | -177.9% | -1,457.4% | -435.2% | |
| -419.0% | -210.1% | -70.5% | -285.7% | -43.7% | -3.1% | -107.3% | -60.0% | -181.2% | -220.7% | -54.0% | -339.1% | -233.8% | -426.0% | -4.3% | -93.4% | -80.1% | -86.2% | -93.6% | -114.0% | -124.5% | -125.4% | -347.1% | -224.7% | -247.4% | -7.0% | -7.7% | 1.8% | 27.4% | 9.0% | 34.5% | -24.0% | 18.6% | 50.8% | 47.1% | 1.4% | -235.4% | -3,913.4% | -174.9% | -1,432.2% | -427.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.